Literature DB >> 26581002

HABP2 Mutation and Nonmedullary Thyroid Cancer.

Ximeng Zhao, Xiaoyi Li, Xue Zhang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26581002     DOI： 10.1056/NEJMc1511631

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

1.  RE: HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer.

Authors:  Luis G Carvajal-Carmona; Ian Tomlinson; Ruta Sahasrabudhe
Journal:  J Natl Cancer Inst       Date:  2016-05-06       Impact factor: 13.506

2.  G534E Variant in HABP2 and Nonmedullary Thyroid Cancer.

Authors:  Macarena Ruiz-Ferrer; Raquel M Fernández; Elena Navarro; Guillermo Antiñolo; Salud Borrego
Journal:  Thyroid       Date:  2016-07       Impact factor: 6.568

3.  Next Generation Sequencing and Association Studies in Familial Nonmedullary Thyroid Carcinoma: Let's Choose Appropriate Controls.

Authors:  Laure Cazabat; Aglae Terray; Philippe de Mazancourt; Jacques Ropers; Lionel Groussin; Marie-Laure Raffin-Sanson
Journal:  Eur Thyroid J       Date:  2017-06-23

4.  Non-medullary Thyroid Cancer Susceptibility Genes: Evidence and Disease Spectrum.

Authors:  Jingan Zhou; Preeti Singh; Kanhua Yin; Jin Wang; Yujia Bao; Menghua Wu; Kush Pathak; Sophia K McKinley; Danielle Braun; Carrie C Lubitz; Kevin S Hughes
Journal:  Ann Surg Oncol       Date:  2021-03-03       Impact factor: 5.344

5.  HABP2 germline variants are uncommon in familial nonmedullary thyroid cancer.

Authors:  Alexia L Weeks; Scott G Wilson; Lynley Ward; Jack Goldblatt; Jennie Hui; John P Walsh
Journal:  BMC Med Genet       Date:  2016-08-17       Impact factor: 2.103

6.  The p.G534E variant of HABP2 is not associated with sporadic papillary thyroid carcinoma in a Polish population.

Authors:  Artur Kowalik; Danuta Gąsior-Perczak; Martyna Gromek; Monika Siołek; Agnieszka Walczyk; Iwona Pałyga; Małgorzata Chłopek; Janusz Kopczyński; Ryszard Mężyk; Aldona Kowalska; Stanisław Góźdź
Journal:  Oncotarget       Date:  2017-04-06

7.  The HABP2 G534E polymorphism does not increase nonmedullary thyroid cancer risk in Hispanics.

Authors:  Mabel E Bohórquez; Ana P Estrada; Jacob Stultz; Ruta Sahasrabudhe; John Williamson; Paul Lott; Carlos S Duque; Jorge Donado; Gilbert Mateus; Fernando Bolaños; Alejandro Vélez; Magdalena Echeverry; Luis G Carvajal-Carmona
Journal:  Endocr Connect       Date:  2016-04-20       Impact factor: 3.335

8.  Pitfalls of exome sequencing: a case study of the attribution of HABP2 rs7080536 in familial non-medullary thyroid cancer.

Authors:  Glenn S Gerhard; Darrin V Bann; James Broach; David Goldenberg
Journal:  NPJ Genom Med       Date:  2017-03-28       Impact factor: 8.617

9.  Familial Cancer Variant Prioritization Pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer family.

Authors:  Abhishek Kumar; Obul Reddy Bandapalli; Nagarajan Paramasivam; Sara Giangiobbe; Chiara Diquigiovanni; Elena Bonora; Roland Eils; Matthias Schlesner; Kari Hemminki; Asta Försti
Journal:  Sci Rep       Date:  2018-08-02       Impact factor: 4.379

10.  Pedigree based DNA sequencing pipeline for germline genomes of cancer families.

Authors:  Asta Försti; Abhishek Kumar; Nagarajan Paramasivam; Matthias Schlesner; Calogerina Catalano; Dagmara Dymerska; Jan Lubinski; Roland Eils; Kari Hemminki
Journal:  Hered Cancer Clin Pract       Date:  2016-08-09       Impact factor: 2.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.